SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Uroplasty, Inc. of Class Action Challenging the Fairness of...
January 16 2015 - 9:58AM
Levi & Korsinsky notifies shareholders of Uroplasty, Inc.
("Uroplasty" or "the Company") (Nasdaq:UPI) of claims of breaches
of fiduciary duty and other violations of state law against the
board of directors of the Company in connection with the sale of
the Company to Vision-Sciences, Inc. (Nasdaq:VSCI). A complaint was
filed in Minnesota state court.
Click here to learn more about the action:
http://zlk.9nl.com/uroplasty.
Under the terms of the transaction, Uroplasty shareholders will
receive 3.6331 shares of Vision-Sciences common stock for each
share of Uroplasty stock they own. The claims concern whether the
Board of Uroplasty breached their fiduciary duties to stockholders
by failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Vision-Sciences, Inc. is
underpaying for Uroplasty shares.
If you own Uroplasty common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit
http://zlk.9nl.com/uroplasty.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm's
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT: Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Cognyte Software (NASDAQ:CGNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cognyte Software (NASDAQ:CGNT)
Historical Stock Chart
From Apr 2023 to Apr 2024